Howard Feldman
Impact in
- Psychiatry and Mental health top 0.02%
- Dementia and Cognitive Impairment Research
- Neurology top 0.05%
- Amyotrophic Lateral Sclerosis Research
- Parkinson's Disease Mechanisms and Treatments
- Neurological Disease Mechanisms and Treatments
Papers in
-
- Dementia and Cognitive Impairment Research 104
- Physiology 74
- Alzheimer's disease research and treatments 71
- Co-authors
- Bruno Dubois (11 shared papers)Steven T. DeKosky (4 shared papers)María C. Carrillo (9 shared papers)Ronald C. Petersen (8 shared papers)William J. Jagust (3 shared papers)Dennis W. Dickson (4 shared papers)Peter J. Snyder (3 shared papers)Nick C. Fox (3 shared papers)
- Journals
- Alzheimer s & Dementia (50 papers)Neurology (16 papers)Neurobiology of Aging (12 papers)Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (12 papers)Alzheimer s & Dementia Translational Research & Clinical Interventions (10 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Howard Feldman
233 papers receiving 31.6k citations
Howard Feldman's Hit Papers
Peers
Comparison fields: 5 of 180
- Psychiatry and Mental health 11.9k
- Neurology 4.0k
- Neurology 6.9k
- Physiology 9.4k
- Biological Psychiatry 518
Countries citing papers authored by Howard Feldman
This map shows the geographic impact of Howard Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Feldman more than expected).
Fields of papers citing papers by Howard Feldman
This network shows the impact of papers produced by Howard Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Feldman. The network helps show where Howard Feldman may publish in the future.
Co-authors
The 25 scholars most cited alongside Howard Feldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 244 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Hit paper breakdown → | 2011 | 7637 |
| 2 | Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Hit paper breakdown → | 2006 | 5093 |
| 3 | Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria Hit paper breakdown → | 2007 | 3363 |
| 4 | The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease Hit paper breakdown → | 2013 | 2210 |
| 5 | A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers Hit paper breakdown → | 2016 | 1243 |
| 6 | Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group Hit paper breakdown → | 2021 | 657 |
| 7 | Treatment of Alzheimer's disease; current status and new perspectives Hit paper breakdown → | 2003 | 638 |
| 8 | Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup Hit paper breakdown → | 2011 | 595 |
| 9 | Clinical trials and late‐stage drug development for Hit paper breakdown → | 2014 | 540 |
| 10 | Dementia with Lewy bodies Hit paper breakdown → | 2003 | 508 |
| 11 | 2001 | 486 | |
| 12 | 2010 | 425 | |
| 13 | 2010 | 347 | |
| 14 | Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial Hit paper breakdown → | 2016 | 345 |
| 15 | 2010 | 313 | |
| 16 | 2008 | 281 | |
| 17 | 2005 | 275 | |
| 18 | 2006 | 237 | |
| 19 | 2008 | 198 | |
| 20 | 2001 | 195 |
About Howard Feldman
Howard Feldman is a scholar working on Psychiatry and Mental health, Physiology, Neurology, Economics and Econometrics and Neurology, having authored 244 papers that have together received 32.5k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (104 papers), Alzheimer's disease research and treatments (71 papers), Amyotrophic Lateral Sclerosis Research (25 papers), Health Systems, Economic Evaluations, Quality of Life (22 papers), Cholinesterase and Neurodegenerative Diseases (16 papers), Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological Disease Mechanisms and Treatments (9 papers) and Frailty in Older Adults (7 papers). The work is most often cited by research in Psychiatry and Mental health (11.9k citations), Neurology (4.0k citations), Neurology (6.9k citations), Physiology (9.4k citations) and Biological Psychiatry (518 citations). Howard Feldman has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Bruno Dubois, Steven T. DeKosky, María C. Carrillo, Ronald C. Petersen, William J. Jagust, Dennis W. Dickson, Peter J. Snyder, Nick C. Fox, Marilyn S. Albert and David M. Holtzman. Their work appears in journals such as Alzheimer s & Dementia, Neurology, Neurobiology of Aging, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques and Alzheimer s & Dementia Translational Research & Clinical Interventions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.